24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency

Publisher Website
Google Scholar
Abstract
Sustained-release GH formulations may provide a strategy for improving treatment compliance and persistence in GH-deficient patients.